Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05880199 · ClinicalTrials.gov registry record
BSGM to Evaluate Patients With GI Symptoms
A clinical trial of Gastroparesis and Functional Gastrointestinal Disorders, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 685
- Enrollment target
- 5
- Study locations
NCT05880199 is a study of Gastroparesis and Functional Gastrointestinal Disorders that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 685 participants, above the 287-participant average among 44 other Gastroparesis trials with a reported enrollment target (139% higher). The trial reports 5 study locations across 4 states.
The verdict
NCT05880199, a study of Gastroparesis and Functional Gastrointestinal Disorders, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 685 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with GI symptoms as measured by a body surface gastric mapping (BSGM) device. Participants will have their stomach activity recorded for up to 4 hours using the BSGM device and log real-time symptoms. Researchers will compare the recordings of healthy children and children with GI symptoms to define abnormal GI patterns.
Conditions Studied
Interventions
- DEVICE Body surface gastric mapping device
Study Locations (5)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Nationwide Children's Hospital - Columbus
California
- Alliant International University - San Diego
Missouri
- Children's Mercy Hospital - Kansas City
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 685 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2028-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05880199
The ClinicalTrials.gov registry entry for NCT05880199 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 685 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 287-participant average among 44 other Gastroparesis trials with a reported enrollment target (139% higher). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Body surface gastric mapping device is the first listed.
NCT05880199 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Ohio, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT05880199 about?
NCT05880199 is a clinical study titled "BSGM to Evaluate Patients With GI Symptoms". The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with GI symptoms as measured by a body surface gastric mapping (BSGM) device. Participants will have their...
What is the current status of trial NCT05880199?
This trial is currently recruiting. The enrollment target is 685 participants. The study started on 2021-10-01. Estimated completion is 2028-06-30.
What conditions does trial NCT05880199 study?
This clinical trial studies the following conditions: Gastroparesis, Functional Gastrointestinal Disorders, Gastrointestinal Motility Disorders in Children, Dyspepsia and Other Specified Disorders of Function of Stomach.
What interventions are being tested in trial NCT05880199?
The interventions under investigation include: Body surface gastric mapping device (DEVICE).
Who is sponsoring clinical trial NCT05880199?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05880199 being conducted?
This trial has 5 study locations across California, Missouri, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.